Europe clinical trials market was valued at valued at $10,939.1 million in 2022 and will grow by 6.4% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 99 tables and 79 figures, this 186-page report "Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Europe clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.
Based on Product Category, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
• Trials of Devices
• Trials of Procedures
Based on Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Phase I
• Phase II
• Phase III
• Phase IV
By Design, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Interventional Studies
o Randomized Control Trial
o Adaptive Clinical Trial
o Non-randomized Control Trial
• Observational Studies
o Cohort Study
o Case Control Study
o Cross Sectional Study
o Ecological Study
• Expanded Access Trials
By Service Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services
By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of each national market by Phase, Design, and Indication over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PhlexEurope
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 29
2.2 Major Growth Drivers 33
2.3 Market Restraints and Challenges 40
2.4 Emerging Opportunities and Market Trends 43
2.5 Porter's Fiver Forces Analysis 47
3 Segmentation of Europe Market by Product Category 51
3.1 Market Overview by Product Category 51
3.2 Trials of Drugs 53
3.2.1 Small Molecule Drugs 54
3.2.2 Vaccines 55
3.2.3 Cell & Gene Therapy 56
3.2.4 Other Drugs 57
3.3 Trials of Devices 58
3.4 Trials of Procedures 59
4 Segmentation of Europe Market by Phase 60
4.1 Market Overview by Phase 60
4.2 Phase I 62
4.3 Phase II 63
4.4 Phase III 64
4.5 Phase IV 65
5 Segmentation of Europe Market by Design 66
5.1 Market Overview by Design 66
5.2 Interventional Studies 68
5.2.1 Randomized Control Trial 70
5.2.2 Adaptive Clinical Trial 71
5.2.3 Non-randomized Control Trial 72
5.3 Observational Studies 73
5.3.1 Cohort Study 75
5.3.2 Case Control Study 76
5.3.3 Cross Sectional Study 77
5.3.4 Ecological Study 78
5.4 Expanded Access Trials 79
6 Segmentation of Europe Market by Service Type 80
6.1 Market Overview by Service Type 80
6.2 Protocol Designing 82
6.3 Site Identification 83
6.4 Patient Recruitment 84
6.5 Laboratory Services 85
6.6 Bioanalytical Testing Services 86
6.7 Clinical Trial Data Management Services 87
6.8 Clinical Trial Supply & Logistic Services 88
6.9 Decentralized Clinical Trial Services 89
6.10 Medical Device Testing Services 90
6.11 Other Clinical Trial Services 91
7 Segmentation of Europe Market by Indication 92
7.1 Market Overview by Indication 92
7.2 Oncology 94
7.3 Infectious Diseases 95
7.4 Cardiology 96
7.5 Obesity 97
7.6 Diabetes 98
7.7 Neurology 99
7.8 Immunology 100
7.9 Pain Management 101
7.10 Other Indications 102
8 Segmentation of Europe Market by End User 103
8.1 Market Overview by End User 103
8.2 Pharmaceutical and Biotechnological Companies 105
8.3 Clinical Research Organizations 106
8.4 Clinical Testing Laboratories 107
8.5 Other End Users 108
9 European Market 2021-2031 by Country 109
9.1 Overview of European Market 109
9.2 Germany 112
9.3 U.K. 114
9.4 France 116
9.5 Spain 118
9.6 Italy 120
9.7 Russia 122
9.8 Rest of European Market 124
10 Competitive Landscape 126
10.1 Overview of Key Vendors 126
10.2 New Product Launch, Partnership, Investment, and M&A 130
10.3 Company Profiles 131
Accell Clinical Research LLC 131
Charles River Laboratories 133
ClinDatrix Inc 136
Clinipace 137
Eli Lilly and Company 139
F. Hoffmann-La Roche Ltd. 142
ICON PLC 145
IQVIA Holdings, Inc. 148
Laboratory Corporation of America (Covance Inc.) 152
Novo Nordisk AS 156
PAREXEL International Corporation 159
Pfizer Inc. 163
Pharmaceutical Product Development LLC 168
Phlexglobal 171
PRA Health Sciences 173
Sanofi SA 175
SGS SA (SGS Life Sciences) 178
Syneos Health Inc. 181
Wuxi AppTec Inc. 184
RELATED REPORTS 186
The Clinical Trial Simulation Tools Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cloud Computing in Clinical Trials Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
Market Overview
The Europe Vanadium Market is poised for significant growth from 2024 to 2034, driven by increasing demand across diverse industries such as iron and steel production, energy storage, and chemicals. The market is expected to reach USD XX.XX billion by 2034, expanding at ...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The Europe Anti-Pollution Mask Market is anticipated to witness significant growth from 2024 to 2034, driven by rising awareness of air pollution's health impacts and the increasing adoption of protective measures. The market is projected to reach a valuation of USD XX.X...
Market Overview
The Europe Ethnic Wear Market is expected to experience robust growth from 2024 to 2034, fueled by a growing appreciation for traditional and culturally significant apparel, alongside a rising inclination towards fusion wear. The market is projected to attain a valuation...
Market Overview
The Europe FinTech Investment Market is poised for significant expansion from 2024 to 2034, driven by rapid technological advancements, evolving consumer preferences, and the increasing integration of digital finance solutions. The market is expected to reach a valuation...
Market Overview
The Europe Airport Asset Tracking Market is set for substantial growth between 2024 and 2034, fueled by the increasing need for efficient asset management across airports to enhance operational efficiency and minimize asset loss or misplacement. The market is projected t...
Market Overview
The Europe Sustainable Aviation Fuel Market is poised for significant growth from 2024 to 2034, driven by escalating environmental concerns and regulatory pressures to reduce carbon emissions in the aviation sector. The market is projected to reach USD XX.XX billion by 2...